CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

27 hedge funds and large institutions have $8.71M invested in Cyclacel Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
8
Closed
4
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$42K

Top Buyers

1
SSA
1
Schonfeld Strategic Advisors
New York
$1.57M
2
AI
2
Atom Investors
Texas
$96K
3
Citadel Advisors
3
Citadel Advisors
Florida
$71K
4
IC
4
Ikarian Capital
Texas
$319K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$66K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$54K
2
Morgan Stanley
2
Morgan Stanley
New York
$0
3
PVI
3
Pura Vida Investments
New York
$237K
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$2K
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– – -33,762 Closed
Millennium Management
27
Millennium Management
New York
– – -10,093 Closed
Osaic Holdings
28
Osaic Holdings
Arizona
– – -2,000 Closed
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
– – -2,000 Closed
Bank of America
30
Bank of America
North Carolina
$0 116 -153 -57%
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
CSS
32
Cubist Systematic Strategies
Connecticut
$0 2 +2 New
1
2